ARWR vs. QQQ
Compare and contrast key facts about Arrowhead Pharmaceuticals, Inc. (ARWR) and Invesco QQQ (QQQ).
QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARWR or QQQ.
Performance
ARWR vs. QQQ - Performance Comparison
Returns By Period
In the year-to-date period, ARWR achieves a -40.26% return, which is significantly lower than QQQ's 23.84% return. Over the past 10 years, ARWR has underperformed QQQ with an annualized return of 11.51%, while QQQ has yielded a comparatively higher 18.03% annualized return.
ARWR
-40.26%
-10.30%
-25.90%
-36.88%
-18.00%
11.51%
QQQ
23.84%
1.82%
11.65%
30.35%
20.97%
18.03%
Key characteristics
| ARWR | QQQ | |
|---|---|---|
| Sharpe Ratio | -0.55 | 1.78 |
| Sortino Ratio | -0.47 | 2.37 |
| Omega Ratio | 0.94 | 1.32 |
| Calmar Ratio | -0.36 | 2.28 |
| Martin Ratio | -1.01 | 8.27 |
| Ulcer Index | 35.08% | 3.73% |
| Daily Std Dev | 64.31% | 17.37% |
| Max Drawdown | -99.83% | -82.98% |
| Current Drawdown | -97.50% | -1.78% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between ARWR and QQQ is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
ARWR vs. QQQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARWR vs. QQQ - Dividend Comparison
ARWR has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.60%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARWR Arrowhead Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ | 0.60% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% | 1.41% | 1.02% |
Drawdowns
ARWR vs. QQQ - Drawdown Comparison
The maximum ARWR drawdown since its inception was -99.83%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for ARWR and QQQ. For additional features, visit the drawdowns tool.
Volatility
ARWR vs. QQQ - Volatility Comparison
Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 16.73% compared to Invesco QQQ (QQQ) at 5.41%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.